01 12NEUROCRINE
01 1211026939
01 12Blank
01 12Y
01 122038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209241
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209241
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218390
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209241
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209241
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218390
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218390
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209241
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218390
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
Patent Expiration Date : 2038-09-18
US Patent Number : 11026939
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218390
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-18
